Forecasted Earnings Meet Estimates: A Comprehensive Review of Ajinomoto Co (2802) Financial Performance

Ajinomoto Co on Smartkarma

Independent analysts on Smartkarma are closely monitoring Ajinomoto Co, with Clarence Chu providing insights on how a group of shareholders is seeking to raise US$444m through a secondary follow-on. In response to this, Ajinomoto plans to conduct a share buyback of 10 million shares, aiming to ease the impact of the selldown while maintaining market stability. The sell-off, although not widely anticipated, is expected to be manageable given its size relative to the company’s average daily volume.

Another analyst, Travis Lundy, highlights the intricacies of the situation, pointing out that major banks, MUFJ and Mizuho, are unwinding crossholdings in a secondary offering for Ajinomoto. This offering involves 14.3 million shares, alongside a ¥40bn buyback initiative by Ajinomoto. Lundy notes that despite these movements, the overall impact on the market may be limited, given the stock’s low volatility and the gradual increase in available shares over time due to the buyback.

A look at Ajinomoto Co Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

When looking at the long-term outlook for Ajinomoto Co. based on Smartkarma Smart Scores, the company shows promising potential. With a strong Growth score of 4 and Momentum score of 4, Ajinomoto Co. appears to be on a trajectory of expansion and positive market performance. This indicates that the company is likely to experience notable growth in the future and has good momentum to support its development.

While the Value and Dividend scores are more moderate at 2, Ajinomoto Co. scores well on Resilience with a score of 3. This suggests that the company has the ability to weather economic uncertainties and challenges. Overall, Ajinomoto Co., Inc. is a diversified company that produces and sells various food products, pharmaceuticals, amino acids, and specialty chemicals. With a solid Growth and Momentum outlook, the company seems well-positioned for long-term success in its industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma